Decentralized Trial Technology Resources
-
Evidence Generation Evolved
6/13/2024
Explore how innovative strategies are cutting clinical trial times in half and accelerating the delivery of life-saving treatments.
-
The Rapid Digitization Of Trials
11/7/2024
It’s no secret that more trials are going digital. Hear from a panel of industry experts including Sanofi, Bayer, and the Clinical Trials Transformation Initiative (CTTI) as they discuss the evolution of digital trials and share their experiences.
-
Trends Shaping The Pharmaceutical Industry's Future
4/10/2024
Decentralized trials and patient choice are key to expanding study reach. Here, we examine how patient access increases with diverse options and AI-powered connections across health systems and sites.
-
4 Ways Home Visits Support Successful Rare Disease Clinical Trials
4/25/2023
Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.
-
A Better Approach To eConsent: Flexibility With Enabled Technology
1/11/2023
Electronic consent, or eConsent, digitalizes the trial participant consent process through increasingly simplified, interactive, educational models designed to improve comprehension and boost engagement.
-
Taming The Complex Clinical-Trial Ecosystem
4/9/2025
To navigate the growing number of vendor portals required for clinical trials, sites are seeking a vendor- and sponsor-agnostic solution to enable single sign-on and study organization.
-
eSource Enables Speed, Flexibility, And Higher-Quality Data
7/22/2022
A truly integrated eSource Solution, including DDC, eCOA, and eConsent, facilitates remote or decentralized clinical trials by ingesting data from multiple sources and consolidating it into a single data set.
-
The Building Blocks Of DCT: How To Create A Seamless Experience Across eConsent, eCOA, And More
3/29/2022
With more than 76% of sponsors seeking to implement decentralized solutions this year, there’s never been more attention given to decentralized trials. Discover why decentralized trials must take a unified approach, one that alleviates burdens for patients and sites in order to drive cost savings and realize efficiencies.
-
Key Takeaways From The Recent FDA DCT Draft Guidance
8/7/2023
Get an overview of draft perspectives and key points to reinforce decentralized clinical trial training, oversight, and risk assessment to guarantee a study's integrity, patient safety, and success.
-
How To Improve Patient Outcomes Using eSource Software In Clinical Trials
8/11/2025
As the demand for patient-centric clinical trials grows, eSource platforms will play an increasingly vital role in facilitating efficient, compliant, and innovative research methodologies.